SHMT2 and colorectal carcinoma: Similarly, a human colorectal carcinoma showed reduced SHMT2 succinylation under metabolic challenges with serine/glycine deprivation and a mutational approach confirmed that SHMT2 K280E abolished the binding affinity of pyridoxal phosphate (PLP), a critical cofactor to activate the serine/glycine pathway.